ArticlePloS one2017

Implication of the intestinal microbiome as a potential surrogate marker of immune responsiveness to experimental therapies in autoimmune diabetes.

James C Needell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.